Assessment of the role of lipoprotein a level in the development of cardiovascular diseases

Abstract

A comparative trial within 2 groups of patients with cardiovascular diseases who have high and normal levels of lipoprotein (a) was conducted to determine the link between high levels of Lp (a) and the nature of the development of cardiovascular events. According to the results of the study, conclusions about the significance of the level of Lp(a), as well as hypolipidemic therapy in patients with cardiovascular pathology were made. The features of the population of patients with an expected increase in Lp(a) and the predominance of lesions of the brachiocephalic arteries among individuals with increased Lp(a) were revealed. Hypolipidemic statin therapy with a passable correction of the lipid spectrum does not always allow to control the increase in Lp(a).